Role of Cardiovascular Magnetic Resonance as a Gatekeeper to Invasive Coronary Angiography in Patients Presenting With Heart Failure of Unknown Etiology
暂无分享,去创建一个
P. Poole‐Wilson | D. Pennell | M. Cowie | J. Keegan | G. Lloyd | S. Prasad | J. Lyne | R. Assomull | W. Bradlow | A. Gulati | P. Kalra | C. Shakespeare | J. Strange | S. Prasad
[1] Takashi Ohori,et al. Impact of myocardial perfusion abnormality on prognosis in patients with non-ischemic dilated cardiomyopathy. , 2010, Journal of cardiology.
[2] W. Fang,et al. Myocardial ischemia in patients with dilated cardiomyopathy , 2010, Nuclear medicine communications.
[3] J. Estornell-Erill,et al. Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[4] W. Wijns,et al. On the inappropriateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography. , 2009, JACC. Cardiovascular interventions.
[5] D. Berman,et al. Can coronary computed tomographic angiography trigger coronary revascularization? Questioning the appropriateness of the question. , 2009, JACC. Cardiovascular interventions.
[6] Katherine C. Wu,et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[7] D. Pennell,et al. Cardiovascular magnetic resonance in the evaluation of heart failure , 2007, Heart.
[8] D. Andreini,et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy. , 2007, Journal of the American College of Cardiology.
[9] F. Ridocci,et al. Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience. , 2007, International journal of cardiology.
[10] C. Meyer,et al. Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure? , 2007, The International Journal of Cardiovascular Imaging.
[11] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[12] G. Pilz,et al. Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography , 2006, Clinical Research in Cardiology.
[13] R. Senior,et al. Myocardial Contrast Echocardiography for Distinguishing Ischemic From Nonischemic First-Onset Acute Heart Failure: Insights Into the Mechanism of Acute Heart Failure , 2005, Circulation.
[14] F. Ridocci,et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. , 2005, Journal of the American College of Cardiology.
[15] Lippincott Williams Wilkins,et al. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery , 2004 .
[16] K. Kent,et al. Five-Year Follow-Up After Intracoronary Gamma Radiation Therapy for In-Stent Restenosis , 2004, Circulation.
[17] C H Lorenz,et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.
[18] John P Ridgway,et al. Three-dimensional coronary MR angiography performed with subject-specific cardiac acquisition windows and motion-adapted respiratory gating. , 2003, AJR. American journal of roentgenology.
[19] D. Pennell,et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. , 2002, The American journal of cardiology.
[20] C. O'connor,et al. A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.
[21] René M. Botnar,et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. , 2001, The New England journal of medicine.
[22] P. Poole‐Wilson,et al. Coronary artery disease as the cause of incident heart failure in the population. , 2001, European heart journal.
[23] P. Poole‐Wilson,et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. , 2000, Circulation.
[24] D. Firmin,et al. Phase ordering with automatic window selection (PAWS): A novel motion‐resistant technique for 3D coronary imaging , 2000, Magnetic resonance in medicine.
[25] P J Scanlon,et al. ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and , 1999, Circulation.
[26] W. Roberts,et al. Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.
[27] C M O'Connor,et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. , 1997, Journal of the American College of Cardiology.
[28] D. de Bono,et al. Complications of diagnostic cardiac catheterisation: results from 34,041 patients in the United Kingdom confidential enquiry into cardiac catheter complications. The Joint Audit Committee of the British Cardiac Society and Royal College of Physicians of London. , 1993, British heart journal.
[29] L F Burmeister,et al. Proving the Null Hypothesis , 1992, Infection Control & Hospital Epidemiology.
[30] W C Blackwelder,et al. "Proving the null hypothesis" in clinical trials. , 1981, Controlled clinical trials.
[31] M. Clearfield. Rosuvastatin in older patients with systolic heart failure. , 2009, Current atherosclerosis reports.
[32] G. Gensini,et al. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement. , 2006, American heart journal.
[33] Timothy J Gardner,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Circulation.
[34] J. Ornato,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Journal of the American College of Cardiology.
[35] J. Bartko. Proving the null hypothesis. , 1991 .